.jpg)
Essity, a global hygiene and health company, released its financial report for the fourth quarter and full year 2025, outlining the development of its main financial indicators amid a challenging market environment.
FOURTH-QUARTER 2025 FINANCIAL RESULTS
In the fourth quarter of 2025, Essity reported net sales of SEK 34,695 million, representing a decline of 8.2% compared with the same period of the previous year. Organic sales growth was -1.1%, with volume effects of -0.2% and price and mix effects of -0.9%.
Despite lower sales, EBITA increased by 9% to SEK 5,005 million, while the EBITA margin excluding items affecting comparability improved to 14.7%, up from 13.1% in Q4 2024. Profit for the period amounted to SEK 3,224 million, with earnings per share of SEK 4.69.
FULL-YEAR 2025 CONSOLIDATED PERFORMANCE
For the full year 2025, Essity reported net sales of SEK 138,494 million, a decrease of 4.8% compared with the previous year, while organic sales growth reached 0.9%.
Full-year EBITA totaled SEK 19,503 million, in line with the prior year, while EBITA EXCLUDING ITEMS AFFECTING COMPARABILITY declined by 4% to SEK 19,572 million. The EBITA excl. IAC margin improved slightly to 14.1%. Profit for the year was SEK 12,718 million, with earnings per share of SEK 18.37.
HYGIENE, TISSUE AND PERSONAL CARE BUSINESSES
In its press release, Essity highlighted increased market shares across several product segments within its global hygiene and personal care portfolio, which includes tissue and personal care categories. The company also referred to ongoing strategic initiatives related to innovation, operational efficiency and acquisitions aimed at strengthening its market position.
DIVIDEND PROPOSAL
Essity’s Board of Directors proposed a 6% increase in the dividend, to SEK 8.75 per share for the 2025 financial year.
To learn more about the full report, click here.
